1.Lamin B1 regulates the growth of hepatocellular carcinoma cells by influencing telomerase activity.
Ruiguan WANG ; Si CHEN ; Zhijia SUN ; Shikun WANG ; Jie WANG ; Lingmei QIN ; Jiangbo LI
Chinese Journal of Biotechnology 2023;39(4):1609-1620
Lamin B1 (LMNB1) is highly expressed in liver cancer tissues, and its influence and mechanism on the proliferation of hepatocellular carcinoma cells were explored by knocking down the expression of the protein. In liver cancer cells, siRNAs were used to knock down LMNB1. Knockdown effects were detected by Western blotting. Changes in telomerase activity were detected by telomeric repeat amplification protocol assay (TRAP) experiments. Telomere length changes were detected by quantitative real-time polymerase chain reaction (qPCR). CCK8, cloning formation, transwell and wound healing were performed to detect changes in its growth, invasion and migration capabilities. The lentiviral system was used to construct HepG2 cells that steadily knocked down LMNB1. Then the changes of telomere length and telomerase activity were detected, and the cell aging status was detected by SA-β-gal senescence staining. The effects of tumorigenesis were detected by nude mouse subcutaneous tumorigenesis experiments, subsequent histification staining of tumors, SA-β-gal senescence staining, fluorescence in situ hybridization (FISH) for telomere analysis and other experiments. Finally, the method of biogenesis analysis was used to find the expression of LMNB1 in clinical liver cancer tissues, and its relationship with clinical stages and patient survival. Knockdown of LMNB1 in HepG2 and Hep3B cells significantly reduced telomerase activity, cell proliferation, migration and invasion abilities. Experiments in cells and tumor formation in nude mice had demonstrated that stable knockdown of LMNB1 reduced telomerase activity, shortened telomere length, senesced cells, reduced cell tumorigenicity and KI-67 expression. Bioinformatics analysis showed that LMNB1 was highly expressed in liver cancer tissues and correlated with tumor stage and patient survival. In conclusion, LMNB1 is overexpressed in liver cancer cells, and it is expected to become an indicator for evaluating the clinical prognosis of liver cancer patients and a target for precise treatment.
Animals
;
Mice
;
Telomerase/metabolism*
;
Carcinoma, Hepatocellular/genetics*
;
Liver Neoplasms/genetics*
;
Telomere Shortening
;
In Situ Hybridization, Fluorescence
;
Mice, Nude
;
Telomere/pathology*
;
Carcinogenesis
2.The Effect and Mechanism of Novel Telomerase Inhibitor Nilo 22 on Leukemia Cells.
Jing-Jing YIN ; Qian TANG ; Jia-Li GU ; Ya-Fang LI ; Hui-Er GAO ; Mei HE ; Ming YANG ; Wen-Shan ZHANG ; Hui XU ; Chao-Qun WANG ; Ying-Hui LI ; Cui-Gai BAI ; Ying-Dai GAO
Journal of Experimental Hematology 2021;29(4):1056-1064
OBJECTIVE:
To investigate the cytotoxic effect and its mechanism of the micromolecule compound on the leukemia cells.
METHODS:
The cytotoxic effects of 28 Nilotinib derivatives on K562, KA, KG, HA and 32D cell lines were detected by MTT assays, and the compound Nilo 22 was screen out. Cell apoptosis and cell cycle on leukemia cells were detected by flow cytometry. The effect of compound screened out on leukemogenesis potential of MLL-AF9 leukemia mice GFP
RESULTS:
Nilo 22 serves as the most outstanding candidate out of 28 Nilotinib derivatives, which impairs leukemia cell lines, but spares normal hematopoietic cell line. Comparing with Nilotinib, Nilo 22 could induce the apoptosis of GFP
CONCLUSION
Nilo 22 shows a significant cytotoxic effect on mice and human leukemia cells, especially for drug resistance cells. Nilo 22 is a promising anti-leukemia agent to solve the common clinical problems of drug resistance and relapse of leukemia.
Animals
;
Apoptosis/drug effects*
;
Cell Cycle/drug effects*
;
Cell Line, Tumor
;
Humans
;
Leukemia
;
Mice
;
Myeloid-Lymphoid Leukemia Protein/genetics*
;
Telomerase/metabolism*
;
Telomere/metabolism*
3.TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.
Lucy CASSAR ; Craig NICHOLLS ; Alex R PINTO ; Ruping CHEN ; Lihui WANG ; He LI ; Jun-Ping LIU
Protein & Cell 2017;8(1):39-54
Human telomerase reverse transcriptase (hTERT) plays a central role in telomere lengthening for continuous cell proliferation, but it remains unclear how extracellular cues regulate telomerase lengthening of telomeres. Here we report that the cytokine bone morphogenetic protein-7 (BMP7) induces the hTERT gene repression in a BMPRII receptor- and Smad3-dependent manner in human breast cancer cells. Chonic exposure of human breast cancer cells to BMP7 results in short telomeres, cell senescence and apoptosis. Mutation of the BMPRII receptor, but not TGFbRII, ACTRIIA or ACTRIIB receptor, inhibits BMP7-induced repression of the hTERT gene promoter activity, leading to increased telomerase activity, lengthened telomeres and continued cell proliferation. Expression of hTERT prevents BMP7-induced breast cancer cell senescence and apoptosis. Thus, our data suggest that BMP7 induces breast cancer cell aging by a mechanism involving BMPRII receptor- and Smad3-mediated repression of the hTERT gene.
Actin-Related Protein 2
;
genetics
;
metabolism
;
Activin Receptors, Type II
;
genetics
;
metabolism
;
Bone Morphogenetic Protein 7
;
genetics
;
metabolism
;
Bone Morphogenetic Protein Receptors, Type II
;
genetics
;
metabolism
;
Breast Neoplasms
;
genetics
;
metabolism
;
Cellular Senescence
;
Female
;
HeLa Cells
;
Humans
;
MCF-7 Cells
;
Neoplasm Proteins
;
genetics
;
metabolism
;
Protein-Serine-Threonine Kinases
;
genetics
;
metabolism
;
Receptor, Transforming Growth Factor-beta Type II
;
Receptors, Transforming Growth Factor beta
;
genetics
;
metabolism
;
Smad3 Protein
;
genetics
;
metabolism
;
Telomerase
;
genetics
;
metabolism
;
Telomere Homeostasis
4.Vitamin C alleviates aging defects in a stem cell model for Werner syndrome.
Ying LI ; Weizhou ZHANG ; Liang CHANG ; Yan HAN ; Liang SUN ; Xiaojun GONG ; Hong TANG ; Zunpeng LIU ; Huichao DENG ; Yanxia YE ; Yu WANG ; Jian LI ; Jie QIAO ; Jing QU ; Weiqi ZHANG ; Guang-Hui LIU
Protein & Cell 2016;7(7):478-488
Werner syndrome (WS) is a premature aging disorder that mainly affects tissues derived from mesoderm. We have recently developed a novel human WS model using WRN-deficient human mesenchymal stem cells (MSCs). This model recapitulates many phenotypic features of WS. Based on a screen of a number of chemicals, here we found that Vitamin C exerts most efficient rescue for many features in premature aging as shown in WRN-deficient MSCs, including cell growth arrest, increased reactive oxygen species levels, telomere attrition, excessive secretion of inflammatory factors, as well as disorganization of nuclear lamina and heterochromatin. Moreover, Vitamin C restores in vivo viability of MSCs in a mouse model. RNA sequencing analysis indicates that Vitamin C alters the expression of a series of genes involved in chromatin condensation, cell cycle regulation, DNA replication, and DNA damage repair pathways in WRN-deficient MSCs. Our results identify Vitamin C as a rejuvenating factor for WS MSCs, which holds the potential of being applied as a novel type of treatment of WS.
Animals
;
Ascorbic Acid
;
pharmacology
;
Cell Cycle Checkpoints
;
drug effects
;
Cell Line
;
Cellular Senescence
;
drug effects
;
DNA Damage
;
DNA Repair
;
drug effects
;
DNA Replication
;
drug effects
;
Disease Models, Animal
;
Heterochromatin
;
metabolism
;
pathology
;
Humans
;
Mesenchymal Stem Cells
;
metabolism
;
pathology
;
Mice
;
Nuclear Lamina
;
metabolism
;
pathology
;
Reactive Oxygen Species
;
metabolism
;
Telomere Homeostasis
;
drug effects
;
Werner Syndrome
;
drug therapy
;
genetics
;
metabolism
5.Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population.
Sook Kyung DO ; Seung Soo YOO ; Yi Young CHOI ; Jin Eun CHOI ; Hyo Sung JEON ; Won Kee LEE ; Shin Yup LEE ; Jaehee LEE ; Seung Ick CHA ; Chang Ho KIM ; Jae Yong PARK
The Korean Journal of Internal Medicine 2015;30(5):719-726
BACKGROUND/AIMS: A number of genome-wide and candidate gene association studies have identified polymorphisms associated with telomere length in Caucasian populations. This study was conducted to determine the impacts of 17 polymorphisms identified in Caucasians on telomere length in a Korean population. METHODS: Ninety-four healthy individuals were enrolled in this study. Relative telomere length of chromosomes from peripheral blood samples was measured using quantitative polymerase chain reaction. RESULTS: Two polymorphisms, rs10936599 of MYNN and rs412658 of ZNF676, were found to be associated w ith telomere length (under dominant model, p = 0.04; under recessive model, p = 0.001). Three polymorphisms, rs2853669, rs7705526, and rs2736108, at the TERT locus were also associated with telomere length (under recessive model, p = 0.01, p = 0.02, and p = 0.01, respectively). The genotypes of the five polymorphisms associated with short telomere length were considered bad genotypes; telomere length was significantly decreased with increasing number of bad genotypes (p= 1.7 x 10(-5)). CONCLUSIONS: We have identified polymorphisms associated with telomere length in a Korean population.
Adult
;
Aged
;
Asian Continental Ancestry Group/*genetics
;
Case-Control Studies
;
DNA-Binding Proteins/genetics
;
Female
;
Genome-Wide Association Study
;
Genotype
;
Humans
;
Kruppel-Like Transcription Factors/genetics
;
Male
;
Middle Aged
;
Phenotype
;
*Polymorphism, Single Nucleotide
;
Republic of Korea
;
Telomerase/genetics
;
Telomere/*genetics/metabolism
;
*Telomere Homeostasis
;
Zinc Fingers
6.Telomere length and telomerase mutations in peripheral blood leukocytes of children with chronic aplastic anemia.
Xi-Ge WANG ; Xuan WANG ; Song LIU ; Yu-Jie ZHOU ; Dan-Feng WANG
Chinese Journal of Contemporary Pediatrics 2014;16(4):375-379
OBJECTIVETo investigate the change in telomere length and TERC and TERT mutations in peripheral blood leukocytes of children with chronic aplastic anemia (CAA).
METHODSSixty-nine children with CAA were divided into untreated group (n=24) who did not receive immunosuppressive therapy (IST), response group (n=36) who showed response to IST, and non-response group (n=9) who showed no response to IST; another 35 healthy children matched for age and sex were selected as the control group. The telomere-to-single copy gene (T/S) ratio in peripheral blood leukocytes was measured by real-time PCR in all groups. PCR was performed to detect TERC and TERT mutations in all children with CAA.
RESULTSThe untreated and non-response groups had significantly lower T/S ratios than the control and response groups (P<0.01), whereas there was no significant difference in T/S ratio between the response and control groups (P>0.05). TERC and TERT mutations were not found in all children with CAA.
CONCLUSIONSThe change in telomere length in children with CAA may be related to the development and progression of disease. Telomere length measurement may be used as a prognostic indicator in children with CAA.
Adolescent ; Anemia, Aplastic ; drug therapy ; genetics ; Child ; Child, Preschool ; Chronic Disease ; Humans ; Immunosuppressive Agents ; therapeutic use ; Infant ; Leukocytes ; metabolism ; Male ; Mutation ; Telomerase ; genetics ; Telomere
7.Extracting Extra-Telomeric Phenotypes from Telomerase Mouse Models.
Young Hoon SUNG ; Muhammad ALI ; Han Woong LEE
Yonsei Medical Journal 2014;55(1):1-8
Telomerase reverse transcriptase (TERT) is the protein component of telomerase and combined with an RNA molecule, telomerase RNA component, forms the telomerase enzyme responsible for telomere elongation. Telomerase is essential for maintaining telomere length from replicative attrition and thus contributes to the preservation of genome integrity. Although diverse mouse models have been developed and studied to prove the physiological roles of telomerase as a telomere-elongating enzyme, recent studies have revealed non-canonical TERT activities beyond telomeres. To gain insights into the physiological impact of extra-telomeric roles, this review revisits the strategies and phenotypes of telomerase mouse models in terms of the extra-telomeric functions of telomerase.
Animals
;
Mice
;
Mice, Knockout
;
Telomerase/genetics/*metabolism
;
Telomere/metabolism
8.mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome.
Fang YE ; Yu-Mei HE ; Guo-Xia LI ; Li-Na WANG ; Ning JIA ; Rui-Xia MA ; Yan-Ping MA
Journal of Experimental Hematology 2013;21(1):110-115
This study was purposed to explore the relationship between the mRNA expression of telomere protection protein TIN2 and POT1 and the pathogenesis of myelodysplastic syndrome (MDS). The expression of TIN2 and POT1 genes at the mRNA levels were detected by real-time fluorescence quantitative PCR in 51 patients with MDS and 10 normal controls. The results showed that the mRNA expressions of TIN2 in RA/RARS/RCMD/MDS-U, RAEB-1 and RAEB-2 groups according to the World Health Organization criteria were significantly higher than that in the controls (P < 0.05); the mRNA expressions of POT1 in RA/RARS/RCMD/MDS-U, RAEB-1 and RAEB-2 groups were significantly lower than that in the controls (P < 0.05). The mRNA expressions of TIN2 in high-risk group, inter risk-2 group and inter risk-1 group according to the international prognostic scoring system criteria were significantly higher than that in controls (P < 0.05). There was no significant difference between low risk group and the control group. The mRNA expressions of POT1 in high risk group, inter-risk-2 group and inter-risk-1 group were significantly lower than the controls (P < 0.05). There was no significant difference between low risk group and the control group. The mRNA expression of TIN2 in normal chromosome group was significantly lower than that in abnormal chromosome group (P < 0.05). There was no significant difference between normal chromosome group and the control group. The mRNA expression of POT1 in normal chromosome group was significantly higher than that in abnormal chromosome group (P < 0.05). There was no significant difference between normal chromosome group and the control group. It is concluded that the abnormal mRNA expression of TIN2 and POT1 may be involved in the regulation of telomere dynamics of MDS patients, the regulatory mechanism may be related to the telomere length and the pathogenesis of MDS.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Bone Marrow
;
metabolism
;
pathology
;
Case-Control Studies
;
Cell Adhesion Molecules
;
genetics
;
metabolism
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
genetics
;
metabolism
;
pathology
;
RNA, Messenger
;
genetics
;
Telomere
;
metabolism
;
Telomere-Binding Proteins
;
genetics
;
metabolism
;
Young Adult
9.The change of telomere protein in BEAS-2B malignant transformation cell induced by coal tar pitch smoke extracts.
Wei WANG ; Zhi-Tao LI ; Han-Song ZHU ; Yong ZHAO ; Li-Xia WANG ; Zhen YAN ; I Shi-En L ; Dong XU ; Wei-Dong WU ; Yong-Jun WU ; Yi-Ming WU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2011;29(9):678-681
OBJECTIVEBy testing the changes of telomere binding protein in malignant transformation BEAS-2B cells induced by coal tar pitch smoke extracts, to study the role of protection of telomeres 1 (POT1), telomeric repeat binding factor 1 (TRF1) and TRF2 in tumorgenesis that contact with coal tar pitch.
METHODSThe BEAS-2B cells were induced by coal tar pitch smoke extracts to form malignant transformation cell model in vitro. The gene expression levels of mRNA were assessed by real-time quantitative RT-PCR, the protein expression variations were determined by cell culture overslip of immunohistochemical methods.
RESULTSIn malignant transformation cells, the mRNA expression level (POT1: 0.63 ± 0.04, TRF1: 0.36 ± 0.01) and the protein expression level (POT1: 0.36 ± 0.05, TRF1: 0.09 ± 0.03) of POT1 and TRF1 was statistically significant decreased compared to that of BEAS-2B group (mRNA: POT1: 1.00 ± 0.04, TRF1: 1.01 ± 0.16; protein: POT1: 0.55 ± 0.07, TRF1: 0.27 ± 0.07) and DMSO group (mRNA: POT1: 0.89 ± 0.12, TRF1: 0.90 ± 0.08; protein: POT1: 0.55 ± 0.10, TRF1: 0.26 ± 0.04) (P < 0.05); mRNA expression level (1.45 ± 0.07) and the protein expression level (0.88 ± 0.06) of TRF2 was increased compared to that of BEAS-2B group (mRNA: 1.00 ± 0.07, protein: 0.48 ± 0.06) and DMSO group (mRNA: 1.00 ± 0.06, protein: 0.50 ± 0.06) (P < 0.05).
CONCLUSIONThe change of gene and protein expression level in POT1, TRF1, and TRF2 involved in the process that evolved into malignant transformation in bronchial epithelial cells BEAS-2B induced by coal tar pitch smoke extracts.
Cell Line ; Cell Transformation, Neoplastic ; metabolism ; Coal Tar ; toxicity ; Epithelial Cells ; cytology ; metabolism ; pathology ; Humans ; Repetitive Sequences, Nucleic Acid ; Telomere-Binding Proteins ; genetics ; metabolism
10.Molecular regulation of telomerase activity in aging.
Craig NICHOLLS ; He LI ; Jian-Qiu WANG ; Jun-Ping LIU
Protein & Cell 2011;2(9):726-738
The process of aging is mitigated by the maintenance and repair of chromosome ends (telomeres), resulting in extended lifespan. This review examines the molecular mechanisms underlying the actions and regulation of the enzyme telomerase reverse transcriptase (TERT), which functions as the primary mechanism of telomere maintenance and regulates cellular life expectancy. Underpinning increased cell proliferation, telomerase is also a key factor in facilitating cancer cell immortalization. The review focuses on aspects of hormonal regulations of telomerase, and the intracellular pathways that converge to regulate telomerase activity with an emphasis on molecular interactions at protein and gene levels. In addition, the basic structure and function of two key telomerase enzyme components-the catalytic subunit TERT and the template RNA (TERC) are discussed briefly.
Aging
;
genetics
;
metabolism
;
Alternative Splicing
;
Animals
;
Base Sequence
;
DNA Methylation
;
Enzyme Activation
;
Epigenesis, Genetic
;
Gene Expression Regulation, Enzymologic
;
Humans
;
Mice
;
Mutation
;
Neoplasms
;
enzymology
;
genetics
;
Promoter Regions, Genetic
;
Protein Folding
;
RNA
;
genetics
;
metabolism
;
Signal Transduction
;
Sp1 Transcription Factor
;
genetics
;
metabolism
;
Telomerase
;
genetics
;
metabolism
;
Telomere
;
genetics
;
metabolism

Result Analysis
Print
Save
E-mail